These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15954402)

  • 1. [IgA nephropathy].
    Tomino Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():516-20. PubMed ID: 15954402
    [No Abstract]   [Full Text] [Related]  

  • 2. [IgA nephropathy--pathogenesis, pathophysiology, and therapy].
    Narita I; Goto S; Kondo D; Sakatsume M; Gejyo F
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():397-402. PubMed ID: 16523921
    [No Abstract]   [Full Text] [Related]  

  • 3. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
    Locatelli F; Vecchio LD; Pozzi C
    Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effects of RAS inhibitor in IgA nephropathy].
    Kashihara N
    Nihon Jinzo Gakkai Shi; 2008; 50(4):473-7. PubMed ID: 18546877
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis of and therapy for IgA nephropathy].
    Tomino Y
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):483-7. PubMed ID: 15052807
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Yang et al. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Mandal A
    Clin Nephrol; 2006 Mar; 65(3):227; author reply 227-8. PubMed ID: 16550756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gene polymorphisms of renin-angiotensin system in patients with kidney diseases].
    Narita I; Gejyo F
    Nihon Rinsho; 2004 Oct; 62(10):1811-5. PubMed ID: 15500123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA-CD89 complex in IgA nephropathy: a study on molecular function.
    Wiwanitkit V
    Ren Fail; 2006; 28(6):457-9. PubMed ID: 16928613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IgA nephropathy: from predicting progression to treatment].
    Rauta V; Grönhagen-Riska C
    Duodecim; 2006; 122(2):215-22. PubMed ID: 16509071
    [No Abstract]   [Full Text] [Related]  

  • 12. IgA nephritis--ACE inhibitors, steroids etc?
    Wardle EN
    Nephrol Dial Transplant; 2007 Jun; 22(6):1785; author reply 1785. PubMed ID: 17403702
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune complex formation in IgA nephropathy: CD89 a 'saint' or a 'sinner'?
    Boyd JK; Barratt J
    Kidney Int; 2010 Dec; 78(12):1211-3. PubMed ID: 21116273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy.
    Szelestei T; Bähring S; Kovács T; Vas T; Salamon C; Busjahn A; Luft FC; Nagy J
    Am J Kidney Dis; 2000 Sep; 36(3):468-73. PubMed ID: 10977777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative appraisal of treatment options for IgA nephropathy.
    Ballardie FW
    J Am Soc Nephrol; 2007 Nov; 18(11):2806-9. PubMed ID: 17942959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin gene polymorphisms and neurohormonal inhibition.
    Pauly DF
    Heart Fail Clin; 2010 Jan; 6(1):25-6. PubMed ID: 19945057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating the progression in IgA nephropathy.
    Chan JC; Trachtman H
    Nephron Clin Pract; 2006; 104(1):c61-8. PubMed ID: 16741372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crescentic IgA nephropathy in a child: Effect of a new combination therapy.
    Okamoto M; Yokoyama N; Nozu K; Nakanishi K; Yoshikawa N
    Pediatr Int; 2017 Apr; 59(4):501-503. PubMed ID: 28244692
    [No Abstract]   [Full Text] [Related]  

  • 19. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
    Rossing P; Parving HH; de Zeeuw D
    Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
    [No Abstract]   [Full Text] [Related]  

  • 20. Progression of renal disease--can we forget about inhibition of the renin-angiotensin system?
    Mann JF; McClellan WM; Kunz R; Ritz E
    Nephrol Dial Transplant; 2006 Sep; 21(9):2348-51; discussion 2352-3. PubMed ID: 16822789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.